RNA Interference (RNAi) Drug Delivery Market Report

Japan RNA Interference (RNAi) Drug Delivery Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Jan 21, 2020
  • PAGES：221
  • REPORT CODE：GMM443253
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan RNA Interference (RNAi) Drug Delivery market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan RNA Interference (RNAi) Drug Delivery market. Detailed analysis of key players, along with key growth strategies adopted by RNA Interference (RNAi) Drug Delivery industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Sirnaomics Inc

    • Merck & Co. Inc

    • Tacere Therapeutics Inc

    • PhaseRx Inc

    • Traversa Therapeutics Inc

    • Access Pharmaceuticals Inc

    • Silence Therapeutics plc

    • Dicerna Pharmaceuticals Inc

    • Metabolic disorders

    • Calondo Pharmaceuticals Inc

    • Alnylam Pharmaceuticals Inc

    • Marina Biotech Inc

    • Merck & Co Inc

    • RXi Pharmaceuticals Corp

    By Type:

    • Nanoparticle Drug Delivery Technology

    • Pulmonary Drug Delivery Technology

    • Nucleic Acid Drug Delivery Technology

    • Aptamer Drug Delivery Technology

    By End-User:

    • Infectious Diseases

    • Cardiology

    • Oncology

    • Neurology

    • Ophthalmology

    • Metabolic Disorders

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of RNA Interference (RNAi) Drug Delivery Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Nanoparticle Drug Delivery Technology from 2014 to 2026

      • 1.3.2 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Pulmonary Drug Delivery Technology from 2014 to 2026

      • 1.3.3 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Nucleic Acid Drug Delivery Technology from 2014 to 2026

      • 1.3.4 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Aptamer Drug Delivery Technology from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

      • 1.4.2 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.3 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.4 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Neurology from 2014 to 2026

      • 1.4.5 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Ophthalmology from 2014 to 2026

      • 1.4.6 Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of RNA Interference (RNAi) Drug Delivery Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of RNA Interference (RNAi) Drug Delivery by Major Types

      • 3.4.1 Market Size and Growth Rate of Nanoparticle Drug Delivery Technology

      • 3.4.2 Market Size and Growth Rate of Pulmonary Drug Delivery Technology

      • 3.4.3 Market Size and Growth Rate of Nucleic Acid Drug Delivery Technology

      • 3.4.4 Market Size and Growth Rate of Aptamer Drug Delivery Technology

    4 Segmentation of RNA Interference (RNAi) Drug Delivery Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of RNA Interference (RNAi) Drug Delivery by Major End-Users

      • 4.4.1 Market Size and Growth Rate of RNA Interference (RNAi) Drug Delivery in Infectious Diseases

      • 4.4.2 Market Size and Growth Rate of RNA Interference (RNAi) Drug Delivery in Cardiology

      • 4.4.3 Market Size and Growth Rate of RNA Interference (RNAi) Drug Delivery in Oncology

      • 4.4.4 Market Size and Growth Rate of RNA Interference (RNAi) Drug Delivery in Neurology

      • 4.4.5 Market Size and Growth Rate of RNA Interference (RNAi) Drug Delivery in Ophthalmology

      • 4.4.6 Market Size and Growth Rate of RNA Interference (RNAi) Drug Delivery in Metabolic Disorders

    5 Market Analysis by Regions

    • 5.1 Japan RNA Interference (RNAi) Drug Delivery Production Analysis by Regions

    • 5.2 Japan RNA Interference (RNAi) Drug Delivery Consumption Analysis by Regions

    6 Hokkaido RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 6.1 Hokkaido RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 6.2 Hokkaido RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    7 Tohoku RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 7.1 Tohoku RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 7.2 Tohoku RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    8 Kanto RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 8.1 Kanto RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 8.2 Kanto RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    9 Chubu RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 9.1 Chubu RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 9.2 Chubu RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    10 Kinki RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 10.1 Kinki RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 10.2 Kinki RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    11 Chugoku RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 11.1 Chugoku RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 11.2 Chugoku RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    12 Shikoku RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 12.1 Shikoku RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 12.2 Shikoku RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    13 Kyushu RNA Interference (RNAi) Drug Delivery Landscape Analysis

    • 13.1 Kyushu RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major Types

    • 13.2 Kyushu RNA Interference (RNAi) Drug Delivery Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Sirnaomics Inc

      • 14.1.1 Sirnaomics Inc Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Merck & Co. Inc

      • 14.2.1 Merck & Co. Inc Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Tacere Therapeutics Inc

      • 14.3.1 Tacere Therapeutics Inc Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 PhaseRx Inc

      • 14.4.1 PhaseRx Inc Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Traversa Therapeutics Inc

      • 14.5.1 Traversa Therapeutics Inc Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Access Pharmaceuticals Inc

      • 14.6.1 Access Pharmaceuticals Inc Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Silence Therapeutics plc

      • 14.7.1 Silence Therapeutics plc Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Dicerna Pharmaceuticals Inc

      • 14.8.1 Dicerna Pharmaceuticals Inc Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Metabolic disorders

      • 14.9.1 Metabolic disorders Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Calondo Pharmaceuticals Inc

      • 14.10.1 Calondo Pharmaceuticals Inc Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Alnylam Pharmaceuticals Inc

      • 14.11.1 Alnylam Pharmaceuticals Inc Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Marina Biotech Inc

      • 14.12.1 Marina Biotech Inc Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Merck & Co Inc

      • 14.13.1 Merck & Co Inc Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 RXi Pharmaceuticals Corp

      • 14.14.1 RXi Pharmaceuticals Corp Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 149 Figures and 168 Tables)

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Nanoparticle Drug Delivery Technology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Pulmonary Drug Delivery Technology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Nucleic Acid Drug Delivery Technology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Aptamer Drug Delivery Technology from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Neurology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Ophthalmology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of RNA Interference (RNAi) Drug Delivery Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of RNA Interference (RNAi) Drug Delivery

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of RNA Interference (RNAi) Drug Delivery by Different Types from 2014 to 2026

    • Table Consumption Share of RNA Interference (RNAi) Drug Delivery by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Nanoparticle Drug Delivery Technology

    • Figure Market Size and Growth Rate of Pulmonary Drug Delivery Technology

    • Figure Market Size and Growth Rate of Nucleic Acid Drug Delivery Technology

    • Figure Market Size and Growth Rate of Aptamer Drug Delivery Technology

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of RNA Interference (RNAi) Drug Delivery by Different End-Users from 2014 to 2026

    • Table Consumption Share of RNA Interference (RNAi) Drug Delivery by Different End-Users from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Neurology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Ophthalmology from 2014 to 2026

    • Figure Japan RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • Table Japan RNA Interference (RNAi) Drug Delivery Production by Regions

    • Table Japan RNA Interference (RNAi) Drug Delivery Production Share by Regions

    • Figure Japan RNA Interference (RNAi) Drug Delivery Production Share by Regions in 2014

    • Figure Japan RNA Interference (RNAi) Drug Delivery Production Share by Regions in 2018

    • Figure Japan RNA Interference (RNAi) Drug Delivery Production Share by Regions in 2026

    • Table Japan RNA Interference (RNAi) Drug Delivery Consumption by Regions

    • Table Japan RNA Interference (RNAi) Drug Delivery Consumption Share by Regions

    • Figure Japan RNA Interference (RNAi) Drug Delivery Consumption Share by Regions in 2014

    • Figure Japan RNA Interference (RNAi) Drug Delivery Consumption Share by Regions in 2018

    • Figure Japan RNA Interference (RNAi) Drug Delivery Consumption Share by Regions in 2026

    • Table Hokkaido RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Hokkaido RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Hokkaido RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Tohoku RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Tohoku RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Tohoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Kanto RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Kanto RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kanto RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Chubu RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Chubu RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Chubu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Kinki RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Kinki RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kinki RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Chugoku RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Chugoku RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Chugoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Shikoku RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Shikoku RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Shikoku RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Kyushu RNA Interference (RNAi) Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2014

    • Figure Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2018

    • Figure Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by Types in 2026

    • Table Kyushu RNA Interference (RNAi) Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kyushu RNA Interference (RNAi) Drug Delivery Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Sirnaomics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics Inc

    • Figure Sales and Growth Rate Analysis of Sirnaomics Inc

    • Figure Revenue and Market Share Analysis of Sirnaomics Inc

    • Table Product and Service Introduction of Sirnaomics Inc

    • Table Company Profile and Development Status of Merck & Co. Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co. Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co. Inc

    • Figure Revenue and Market Share Analysis of Merck & Co. Inc

    • Table Product and Service Introduction of Merck & Co. Inc

    • Table Company Profile and Development Status of Tacere Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tacere Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Tacere Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Tacere Therapeutics Inc

    • Table Product and Service Introduction of Tacere Therapeutics Inc

    • Table Company Profile and Development Status of PhaseRx Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PhaseRx Inc

    • Figure Sales and Growth Rate Analysis of PhaseRx Inc

    • Figure Revenue and Market Share Analysis of PhaseRx Inc

    • Table Product and Service Introduction of PhaseRx Inc

    • Table Company Profile and Development Status of Traversa Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Traversa Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Traversa Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Traversa Therapeutics Inc

    • Table Product and Service Introduction of Traversa Therapeutics Inc

    • Table Company Profile and Development Status of Access Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Access Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Access Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Access Pharmaceuticals Inc

    • Table Product and Service Introduction of Access Pharmaceuticals Inc

    • Table Company Profile and Development Status of Silence Therapeutics plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics plc

    • Figure Sales and Growth Rate Analysis of Silence Therapeutics plc

    • Figure Revenue and Market Share Analysis of Silence Therapeutics plc

    • Table Product and Service Introduction of Silence Therapeutics plc

    • Table Company Profile and Development Status of Dicerna Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals Inc

    • Table Product and Service Introduction of Dicerna Pharmaceuticals Inc

    • Table Company Profile and Development Status of Metabolic disorders

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metabolic disorders

    • Figure Sales and Growth Rate Analysis of Metabolic disorders

    • Figure Revenue and Market Share Analysis of Metabolic disorders

    • Table Product and Service Introduction of Metabolic disorders

    • Table Company Profile and Development Status of Calondo Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calondo Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Calondo Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Calondo Pharmaceuticals Inc

    • Table Product and Service Introduction of Calondo Pharmaceuticals Inc

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals Inc

    • Table Product and Service Introduction of Alnylam Pharmaceuticals Inc

    • Table Company Profile and Development Status of Marina Biotech Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marina Biotech Inc

    • Figure Sales and Growth Rate Analysis of Marina Biotech Inc

    • Figure Revenue and Market Share Analysis of Marina Biotech Inc

    • Table Product and Service Introduction of Marina Biotech Inc

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of RXi Pharmaceuticals Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi Pharmaceuticals Corp

    • Figure Sales and Growth Rate Analysis of RXi Pharmaceuticals Corp

    • Figure Revenue and Market Share Analysis of RXi Pharmaceuticals Corp

    • Table Product and Service Introduction of RXi Pharmaceuticals Corp

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US